Intrinsiqq
Kewaunee Scientific Corporation logo

Kewaunee Scientific Corporation Financials

KEQU

⊜ Compare

All currency values in $ millions unless otherwise noted

Scroll

Showing 6 of 18 available years
Income Statement
TTM
APR 2026
APR 2025
APR 2024
APR 2023
APR 2022
Revenues
Revenue$277$282$240$204$219$169
Cost of Revenue$198$202$172$152$184$145
Gross Profit$79$80$69$52$36$24
Research & Development–$1$1$1$1$1
Provision for Doubtful Accounts$0$0$0$0$0$0
Total Operating Expenses$64$64$51$34$30$27
Operating Income$15$17$18$18$5-$3
Non-Operating
Net Interest Expense-$3-$4-$3-$2-$2-$1
Other Non-Operating Income (Expense)$1$1$0-$3$1$1
EBT (Earnings Before Tax)$12$14$15$13$4-$2
Income Tax Expense$3$3$3-$6$3$4
Minority Interest$1$1$0$0$1$0
Net Income
Net Income$8$10$11$19$1-$6
Per Share Data
Revenue Per Share$94.90$94.54$80.72$69.35$75.64$60.61
EPS (Basic)$2.87$3.36$3.98$6.51$0.26-$2.20
EPS (Diluted)$2.76$3.22$3.83$6.38$0.25-$2.20
Weighted Avg Shares (Basic)2.9M2.9M2.9M2.9M2.8M2.8M
Weighted Avg Shares (Diluted)2.9M3.0M3.0M2.9M2.9M2.8M
Shares Outstanding2.9M3.0M3.0M2.9M2.9M2.8M

Kewaunee Scientific (KEQU) financials: revenue, profit and margins

Kewaunee Scientific (KEQU) generated about $277 million in revenue and $8 million in net income (a 3.0% net margin) over the trailing twelve months, growing at roughly 13.8% a year. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

What is Kewaunee Scientific's (KEQU) revenue?+

Kewaunee Scientific generated about $277 million in revenue over the trailing twelve months. Revenue has grown at roughly 13.8% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Kewaunee Scientific profitable?+

Yes, Kewaunee Scientific reported about $8 million in net income over the trailing twelve months, a net profit margin of roughly 3.0%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Kewaunee Scientific's profit margins?+

Kewaunee Scientific runs a gross margin of about 28.6%, an operating margin of about 5.4%, a net margin of about 3.0%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Kewaunee Scientific growing?+

Kewaunee Scientific's revenue has compounded at roughly 13.8% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside KEQU's margins and free cash flow. This is analysis from SEC filings, not investment advice.

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 8 Sept 2026, covering the period ending 31 Jul 2026, as reported to the SEC. Data last refreshed 12 Sept 2026. How this is calculated.

Fiscal year ends Apr.

Peers

Laboratory Apparatus & Furniture · Pick stocks to compare with KEQU

CompareIntrinsic value
MLABMesa Laboratories Inc.
$126.19+0.57%59
TRNSTranscat Inc.
$108.13+20.79%40
CTKBCytek Biosciences, Inc.
$5.88-1.34%50
HURCHurco Companies, Inc.
$21.24-3.63%43
PACBPacific Biosciences of California, Inc.
$2.55+4.51%26
QTRXQuanterix Corporation
$3.04+3.40%24
INTTIntest Corporation
$14.00-4.63%4
SYPRSypris Solutions Inc.
$1.27-5.22%3

Held by ETFs

KEQU is in 4 US ETFs. The largest of them, with KEQU's weight in each:

Spot a number that looks wrong? Check it in KEQU's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing KEQU

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.